The Journal of Japanese College of Angiology
Online ISSN : 1880-8840
Print ISSN : 0387-1126
ISSN-L : 0387-1126
Volume 59 , Issue 2
Showing 1-1 articles out of 1 articles from the selected issue
Review Article
  • Yoshiki Sawa
    2019 Volume 59 Issue 2 Pages 5-10
    Published: February 10, 2019
    Released: February 10, 2019

    The natural course of aortic stenosis (AS) is generally considered as poor prognosis, and standard treatment of AS is surgical aortic valve replacement (AVR). Transcatheter aortic valve replacement (TAVR) is the treatment that has emerged as minimally invasive treatment for elderly or high-risk AS patients who are generally considered difficult to indicate the surgical AVR. TAVR has become widespread as a new treatment for AS patients along with the evolution of devices, and has been spreading explosively since it was approved in Japan in October 2013. This time, I will introduce the present situation and perspective of TAVR.

    Download PDF (1421K)